Centers | ||
|
|
|
Centre for Collaborative Drug Research | EU-OPENSCREEN | Drug Discovery Core |
The Centre for Collaborative Drug Research is a multidisciplinary initiative bringing together the Faculties of Medicine and Pharmacy at the University of Toronto, Canadas leading academic institution and largest research entity, and the Centre... |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
The Drug Discovery Core at the University of Utah is an established Service/Recharge center that provides compound collections for screening by University of Utah Faculty. Our mission is to provide customers low-cost and efficient access to chemical... |
Partnerships |
Events |
Jobs |
UCB To Fund "Mining the Human Microbiome" Project at HarvardUCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of three years to immunologists at Harvard to study the... View all GSK and MD Anderson to co-develop new cancer therapeuticsGlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the... View all Pharma and Academia Consortium Partner to Develop New Drugs in EuropeA consortium of academic institutes from Germany, Britain, Netherlands and Denmark partner with a group of leading pharmaceutical companies which include AstraZeneca, Sanofi, Bayer, UCB , Lundbeck , Merck KGaA, and Janssen which is a JNJ... View all |
No EVENTS for listing |
No Job Posts |
